Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)

SHE:002581 Revenue

Shandong Sinobioway Biomedicine had revenue of 100.15M CNY in the quarter ending September 30, 2026, with 60.86% growth. This brings the company's total for the last twelve months to 335.96M, up 87.98% year-over-year. In the year 2025, Shandong Sinobioway Biomedicine had annual revenue of 274.81M, down -23.75%. That makes Shandong Sinobioway Biomedicine the 27,952nd largest company in the world by revenue and 4,802nd in China.

• Revenue (ttm): 335.96M
• Revenue Growth: +87.98%
• P/S Ratio: 8.56
• Revenue / Employee: 682.85K
• Employees: 492
• Market Cap: 2.88B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Biopharmaceutical 188.68M 68.7%
• Traditional Chinese Medicine Decoction Pieces Processing 83.07M 30.2%
• Pharmaceutical Distribution 2.99M 1.1%
• Unallocated Other 74.24K 0.0%

Fiscal year ended Dec 31, 2025 See the full SHE:002581 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	274.81M	-85.60M	-23.75%
Dec 31, 2024	360.41M	-69.39M	-16.14%
Dec 31, 2023	429.79M	72.71M	20.36%
Jan 1, 2023	357.08M	-45.63M	-11.33%
Jan 1, 2022	402.71M	125.88M	45.47%

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error